Drug and supplement recalls
A no-JavaScript view of recent drug and supplement recalls in the latest Recall Radar snapshot. For the compact cross-category view, use the snapshot summary. To compare product, firm, code, and reason clues, use the private match checker, product clue index, code clue index, reason clue index, or search starter links. For all loaded records, use the latest recall digest, the newly reported recalls page, the report-date index, the source status page, the nationwide recalls page, the location clue index, the highest concern page, the ongoing recalls page, the recall action checklist, the recall field guide, or interactive Recall Radar Drugs filter.
Not Yet Classified
Ongoing
Reported Sep 16, 2026
fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville, AR, NDC 73013-1013-01.
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Nationwide within the U.S
- Firm
- OurPharma LLC
- Recall began
- Sep 3, 2026
- Quantity
- 1,610 bags
- Codes
- Lot #: 101301260605, BUD: 12/9/2026.
- FDA IDs
- Not specified / event 99837
Class III
Ongoing
Reported Sep 16, 2026
Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
Nationwide within the U.S
- Firm
- Ajanta Pharma USA Inc
- Recall began
- Aug 25, 2026
- Quantity
- 403,200 tablets
- Codes
- Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.
- FDA IDs
- D-0836-2026 / event 99733
Class III
Ongoing
Reported Sep 16, 2026
Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 078...
Subpotent Drug
USA Nationwide
- Firm
- ImprimisRx NJ LLC
- Recall began
- Aug 24, 2026
- Quantity
- 772 bottles
- Codes
- Lot #: 26JAN035, BUD 09/07/2026; 26FEB015, BUD 09/24/2026
- FDA IDs
- D-0835-2026 / event 99756
Class I
Ongoing
Reported Sep 16, 2026
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
U.S. Nationwide.
- Firm
- Baxter Healthcare Corporation
- Recall began
- Aug 17, 2026
- Quantity
- 606 bags
- Codes
- Lot #: Y495066, Exp. Date July 31, 2027
- FDA IDs
- D-0850-2026 / event 99679
Class III
Ongoing
Reported Sep 9, 2026
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus P...
Failed dissolution specifications.
US Nationwide.
- Firm
- Supernus Pharmaceuticals, Inc.
- Recall began
- Aug 31, 2026
- Quantity
- 11304 bottles
- Codes
- Lot# 2145283, Exp Date: 31-Mar-2030.
- FDA IDs
- D-0833-2026 / event 99767
Class II
Ongoing
Reported Sep 9, 2026
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsip...
Presence of Foreign Tablets/Capsules
U.S. Nationwide
- Firm
- Teva Pharmaceuticals USA, Inc
- Recall began
- Aug 24, 2026
- Quantity
- 175,392 bottles
- Codes
- Lot: 1394026, Exp. 02/2028.
- FDA IDs
- D-0834-2026 / event 99734
Class III
Ongoing
Reported Sep 9, 2026
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual...
Labeling: Label Mix-up
US Nationwide.
- Firm
- American Health Packaging
- Recall began
- Aug 19, 2026
- Quantity
- 10,953 cartons.
- Codes
- Lot # 1030023, Exp Date: 06/30/2027.
- FDA IDs
- D-0840-2026 / event 99674
Class II
Ongoing
Reported Sep 9, 2026
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 600...
CGMP Deviations
US Nationwide; Puerto Rico; and Chile.
- Firm
- Baxter Healthcare Corporation
- Recall began
- Aug 6, 2026
- Quantity
- N/A
- Codes
- Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028.
- FDA IDs
- D-0811-2026 / event 99500
Class II
Ongoing
Reported Sep 9, 2026
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthc...
CGMP Deviations
US Nationwide; Puerto Rico; and Chile.
- Firm
- Baxter Healthcare Corporation
- Recall began
- Aug 6, 2026
- Quantity
- N/A
- Codes
- Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027.
- FDA IDs
- D-0813-2026 / event 99500
Class II
Ongoing
Reported Sep 9, 2026
Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield...
CGMP Deviations
US Nationwide; Puerto Rico; and Chile.
- Firm
- Baxter Healthcare Corporation
- Recall began
- Aug 6, 2026
- Quantity
- N/A
- Codes
- Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027.
- FDA IDs
- D-0815-2026 / event 99500
Class II
Ongoing
Reported Sep 9, 2026
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Co...
CGMP Deviations
US Nationwide; Puerto Rico; and Chile.
- Firm
- Baxter Healthcare Corporation
- Recall began
- Aug 6, 2026
- Quantity
- N/A
- Codes
- Lot # NC193856, Exp Date: 04/18/2028.
- FDA IDs
- D-0821-2026 / event 99500
Class I
Ongoing
Reported Sep 9, 2026
Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only,...
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
USA Nationwide.
- Firm
- OPTIMAL BALANCE PHARMACY
- Recall began
- Aug 5, 2026
- Quantity
- 53 vials
- Codes
- Lot#: LG342009076, Beyond Use Date: 10/4/26
- FDA IDs
- D-0851-2026 / event 99662